Bio-Rad Laboratories Inc. (BIO) Tops Q4 EPS Views; Revs Light
Tweet Send to a FriendGet Alerts BIO Hot Sheet
Price: $114.08 +0.47%
EPS Growth %: -37.6%
Financial Fact:
Net loss (income) attributable to noncontrolling interests: -21K
Today's EPS Names:
CO, JW-A, FDS, More
EPS Growth %: -37.6%
Financial Fact:
Net loss (income) attributable to noncontrolling interests: -21K
Today's EPS Names:
CO, JW-A, FDS, More
Trade BIO Now!
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q4 EPS of $2.08, $0.41 better than the analyst estimate of $1.67. Revenue for the quarter came in at $550.2 million versus the consensus estimate of $562.06 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
- Cherokee, Inc. (CHKE) Misses Q1 EPS by 7c
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
